wpostServer: http://css.washingtonpost.com/wpost

Novartis to Restructure U.S. Business, Cut Jobs

Novartis to Restructure U.S. Business, Cut Jobs

Jan. 13, 2012
Jan. 13 (Bloomberg) -- Novartis AG plans to book a $900 million charge as its reassesses the sale potential of its Rasilez drug and said it will cut 1,960 jobs in the U.S. to prepare for the expiry of a patent on its Diovan medicine. Nicole Itano reports on Bloomberg Television's "Countdown" with Linzie Janis and Mark Barton.
Bloomberg
Correction: Clarification:

Loading...

Comments

Add your comment
 
Read what others are saying About Badges
    Section:/business